Search Results

LuminUltra launches latest molecular diagnostic innovation with the GeneCount Corrosion Collection

LuminUltra, the global leader in applied molecular diagnostics, announced today the launch of the LuminUltra GeneCount® qPCR Corrosion Collection — a complete suite of DNA-based monitoring tools to address microbiologically influenced corrosion (MIC).

November 1, 2022

·

4 min read

Universal PropTech Inc. Announces Agreement with LuminUltra Technologies to Provide SARS-CoV-2 (COVID-19) Surface Testing

The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.

February 9, 2021

·

5 min read

LuminUltra Files Patent for the World’s First Rapid, On-site COVID-19 Wastewater Testing Solution

A Research Collaboration Between LuminUltra, Dalhousie University and Halifax Water Demonstrates Wastewater Data Is a Powerful Tool in Early Detection and Tracking COVID-19 Prevalence within Communities

October 21, 2020

·

5 min read

Deals

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19

November 30, 2020

·

4 min read

Made-in-Canada COVID Testing Now Available: LuminUltra Receives Health Canada Authorization for Rapid, Portable COVID-19 qPCR Testing Solutions

Biotechnology front-runner LuminUltra is pleased to announce that it has received Health Canada authorization to sell and distribute its GeneCount® COVID-19 RT-qPCR Assay Kit

December 3, 2020

·

3 min read

LuminUltra and BuiltSpace partner with UBC scientists to test cleaning protocols, reducing the risk of COVID-19 spread in indoor educational spaces

Biotechnology leader LuminUltra has partnered with BuiltSpace, a building data and asset tracking specialist, and scientists at the University of British Columbia to test the effectiveness of disinfection efforts in educational settings for early detection of SARS-CoV-2, the virus that causes COVID-19.

December 14, 2020

·

3 min read

LuminUltra Will Supply 500,000 COVID-19 Tests per Week to Canadian Government

Canadian biotechnology leader LuminUltra announced that it will provide 500,000 urgently needed COVID-19 tests per week to the Canadian federal government for use across Canada.

April 15, 2020

·

2 min read

Biotechnology Leader LuminUltra Submits COVID-19 Clinical Diagnostic Testing Kit for Regulatory Authorization in U.S., Canada

Canada-based biotechnology front-runner LuminUltra announced today that it has submitted its GeneCount® COVID-19 RT-qPCR Assay Kit (COVID-19 Assay) to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) and to Health Canada for an Interim Order (IO).

September 14, 2020

·

3 min read

Business

LuminUltra And Source Molecular Launch Strategic Partnership To Increase Environmental Testing For SARS-CoV-2 In North America

LuminUltra, the Canadian biotechnology leader and developer of the GeneCount qPCR system, and Florida-based Source Molecular, a leader in pathogen testing, today announced a strategic partnership designed to increase environmental testing for SARS-CoV-2 in North America

June 1, 2020

·

5 min read

LuminUltra partners with The Infection Prevention Strategy to educate on proper COVID-19 disinfection protocol

Partnership brings together leaders in their respective fields to advocate for an innovative, science-based approach to pandemic management

November 18, 2020

·

4 min read